Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial

被引:14
|
作者
Ghanaatgar, Milad [1 ]
Taherzadeh, Sina [2 ]
Ariyanfar, Shadi [3 ]
Razeghi, Jahromi Soodeh [1 ]
Martami, Fahime [4 ]
Mahmoudi, Gharaei Javad [5 ]
Teimourpour, Amir [6 ]
Shahrivar, Zahra [1 ,5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Clin Nutr & Dietet, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran
[2] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Tehran, Iran
[3] Washington State Univ, Elson S Floyd Coll Med, Dept Nutr & Exercise Physiol, Vancouver, WA USA
[4] Univ Tehran Med Sci, Sch Nutrit Sci & Dietet, Tehran, Iran
[5] Univ Tehran Med Sci, Roozbeh Hosp, Tehran, Iran
[6] Blood Transfus Res Ctr, High Inst Res & Educ Transfus Med, Tehran, Iran
来源
NUTRITION & FOOD SCIENCE | 2023年 / 53卷 / 01期
关键词
Attention-deficit hyperactivity disorder; ADHD; Probiotics; Children; INTESTINAL PERMEABILITY; STIMULANT MEDICATIONS; GENDER-DIFFERENCES; ALLERGIC DISEASES; ADHD; GUT; INFLAMMATION; ASSOCIATION; MICROBIOTA; SCALE;
D O I
10.1108/NFS-12-2021-0388
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Purpose Accumulating evidence highlights the importance of microbiota-directed intervention in neuropsychiatric disorders. This study aims to investigate the effects of probiotic supplements as an adjunct therapy in combination with Ritalin in children with attention-deficit hyperactivity disorder (ADHD). Design/methodology/approach Children with ADHD, aged 6-12 years, who had an intelligent quotient of >= 70 were enrolled in the study. Participants were randomly assigned to either the group that received probiotics or the group that received the placebo in addition to the weight-adjusted dose of Ritalin. Parents were asked to complete the revised Conners Parent Rating Scale-short version (CPRS-RS), and the psychiatrist completed the seven-point Clinical Global Impression-Severity (CGI-S) scale. Two study groups were compared in three time points, including T1 (before intervention), T2 (at the end of fourth week) and T3 (at the end of the eighth week). Findings A total of 38 participants completed the study. After eight weeks of intervention, the probiotic group had a significant improvement regarding CPRS-RS scores in T2 (9.4 unit, p = 0.014) and T3 (18.6 unit, p < 0.001), compared to placebo. In addition, children in the probiotic group had 0.7 unit lower CGI in T3 (p = 0.018) than the placebo group. A significant reduction of CGI scores was observed in each interval (T2 vs T1, T3 vs T2 and T3 vs T1; p < 0.05). This significant change in CGI score between intervals was also detected in the placebo group in T2 vs T1 (p = 0.002) and T3 vs T1 (p < 0.001). Mean CPRS scores of the groups were different in T2 and T3 (p = 0.011 and p < 0.001, respectively) and mean CGI scores of the two study groups were different in T3 (p = 0.018). Originality/value Eight weeks of supplementation with probiotics had a favorable effect on symptoms and severity of ADHD. Therefore, probiotics as an adjuvant treatment might have a promising efficacy regarding the management of ADHD.
引用
收藏
页码:19 / 34
页数:16
相关论文
共 50 条
  • [1] Clinical and metabolic reaction to probiotic supplement in children suffering attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled experiment
    Sepehrmanesh, Zahra
    Shahzeidi, Ali
    Mansournia, Mohammad Ali
    Ghaderi, Amir
    Ahmadvand, Afshin
    INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2021, 8 (02) : 90 - 96
  • [2] Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial
    Dehbozorghi, Sara
    Bagheri, Sayna
    Moradi, Kamyar
    Shokraee, Kamyar
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2019, 73 (11) : 690 - 696
  • [3] Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial
    Pazoki, Benyamin
    Zandi, Nadia
    Assaf, Zeinab
    Moghaddam, Hossein Sanjari
    Zeinoddini, Arefeh
    Mohammadi, Mohammad Reza
    Akhondzadeh, Shahin
    ADVANCES IN INTEGRATIVE MEDICINE, 2022, 9 (01) : 37 - 43
  • [4] L-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Ghajar, Alireza
    Aghajan-Nashtaei, Farinaz
    Afarideh, Mohsen
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (05) : 331 - 338
  • [5] Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Durell, Todd M.
    Adler, Lenard A.
    Williams, Dave W.
    Deldar, Ahmed
    McGough, James J.
    Glaser, Paul E.
    Rubin, Richard L.
    Pigott, Teresa A.
    Sarkis, Elias H.
    Fox, Bethany K.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 45 - 54
  • [6] Effects of Piracetam as an Adjuvant Therapy on Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alavi, Kaveh
    Shirazi, Elham
    Akbari, Maryam
    Shahrivar, Zahra
    Noori, Fatemeh-Sadat
    Shirazi, Soosan
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2021, 15 (02)
  • [7] The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial
    Hirayama, S.
    Terasawa, K.
    Rabeler, R.
    Hirayama, T.
    Inoue, T.
    Tatsumi, Y.
    Purpura, M.
    Jaeger, R.
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2014, 27 : 284 - 291
  • [8] Vitamin mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial
    Rucklidge, Julia J.
    Frampton, Chris M.
    Gorman, Brigette
    Boggis, Anna
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 204 (04) : 306 - 315
  • [9] Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial
    Johnstone, Jeanette M.
    Hatsu, Irene
    Tost, Gabriella
    Srikanth, Priya
    Eiterman, Leanna P.
    Bruton, Alisha M.
    Ast, Hayleigh K.
    Robinette, Lisa M.
    Stern, Madeline M.
    Millington, Elizabeth G.
    Gracious, Barbara L.
    Hughes, Andrew J.
    Leung, Brenda M. Y.
    Arnold, L. Eugene
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (05): : 647 - 661
  • [10] A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder
    Kahbazi, Manijeh
    Ghoreishi, Aboulfazl
    Rahiminejad, Fatemeh
    Mohammadi, Mohammad-Reza
    Kamalipour, Abbas
    Akhondzadeh, Shahin
    PSYCHIATRY RESEARCH, 2009, 168 (03) : 234 - 237